Comparative study of caudal bupivacaine versus bupivacaine with tramadol for postoperative analgesia in paediatric cancer patients

2013 ◽  
Vol 12 (3) ◽  
pp. 118-122
Author(s):  
Mohammed Hegazy ◽  
Ayman A. Ghoneim
Keyword(s):  
Comparative Study ◽  
Cancer Patients ◽  
Postoperative Analgesia ◽  
Paediatric Cancer

Bloodstream Infections in Paediatric Cancer Patients. Prospective Comparative Study in 2 University Hospitals

2011 ◽  
Vol 223 (06) ◽  
pp. 335-340 ◽  
Author(s):  
T. Krenn ◽  
G. Fleischhack ◽  
O. Moser ◽  
D. Dilloo ◽  
U. Bode ◽  
...  
Keyword(s):  
Comparative Study ◽  
Cancer Patients ◽  
Bloodstream Infections ◽  
Paediatric Cancer ◽  
University Hospitals ◽  
Prospective Comparative Study

Comparative study of Canadian and Hungarian colon cancer patients

2006 ◽  
Vol 44 (05) ◽  
Author(s):  
M Rohánszky ◽  
A Nagy ◽  
G Bodoky ◽  
S Gallinger ◽  
R Gryfe
Keyword(s):  
Colon Cancer ◽  
Comparative Study ◽  
Cancer Patients

Comparative study between epidural tramadol vs buprenorphine for postoperative analgesia

2019 ◽  
Vol 9 (3) ◽  
pp. 240-246
Author(s):  
Sandip Baheti ◽  
◽  
Maya Jamkar ◽  
Kaushik Cherukuri ◽  
◽  
...  
Keyword(s):  
Comparative Study ◽  
Postoperative Analgesia

scholarly journals Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative study

2015 ◽  
Vol 10 (1) ◽  
Author(s):  
Prabhjot Juneja ◽  
Andrew Kneebone ◽  
Jeremy T. Booth ◽  
David I. Thwaites ◽  
Ramandeep Kaur ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Comparative Study ◽  
Cancer Patients ◽  
Prostate Motion

scholarly journals 5-Hydroxyvitamin D concentration in paediatric cancer patients from Scotland: a prospective cohort study

2016 ◽  
Vol 116 (11) ◽  
pp. 1926-1934 ◽  
Author(s):  
Raquel Revuelta Iniesta ◽  
Ilenia Paciarotti ◽  
Isobel Davidson ◽  
Jane M. McKenzie ◽  
Celia Brand ◽  
...  
Keyword(s):  
Cohort Study ◽  
Relative Risk ◽  
Cancer Patients ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Vitamin D Supplementation ◽  
Healthy Children ◽  
Paediatric Cancer ◽  
Hydroxyvitamin D ◽  
Nutritional Data

AbstractChildren with cancer are potentially at a high risk of plasma 25-hydroxyvitamin D (25(OH)D) inadequacy, and despite UK vitamin D supplementation guidelines their implementation remains inconsistent. Thus, we aimed to investigate 25(OH)D concentration and factors contributing to 25(OH)D inadequacy in paediatric cancer patients. A prospective cohort study of Scottish children aged <18 years diagnosed with, and treated for, cancer (patients) between August 2010 and January 2014 was performed, with control data from Scottish healthy children (controls). Clinical and nutritional data were collected at defined periods up to 24 months. 25(OH)D status was defined by the Royal College of Paediatrics and Child Health as inadequacy (<50 nmol/l: deficiency (<25 nmol/l), insufficiency (25–50 nmol/l)), sufficiency (51–75 nmol/l) and optimal (>75 nmol/l). In all, eighty-two patients (median age 3·9, interquartile ranges (IQR) 1·9–8·8; 56 % males) and thirty-five controls (median age 6·2, IQR 4·8–9·1; 49 % males) were recruited. 25(OH)D inadequacy was highly prevalent in the controls (63 %; 22/35) and in the patients (64 %; 42/65) at both baseline and during treatment (33–50 %). Non-supplemented children had the highest prevalence of 25(OH)D inadequacy at every stage with 25(OH)D median ranging from 32·0 (IQR 21·0–46·5) to 45·0 (28·0–64·5) nmol/l. Older age at baseline (R −0·46; P<0·001), overnutrition (BMI≥85th centile) at 3 months (P=0·005; relative risk=3·1) and not being supplemented at 6 months (P=0·04; relative risk=4·3) may have contributed to lower plasma 25(OH)D. Paediatric cancer patients are not at a higher risk of 25(OH)D inadequacy than healthy children at diagnosis; however, prevalence of 25(OH)D inadequacy is still high and non-supplemented children have a higher risk. Appropriate monitoring and therapeutic supplementation should be implemented.

Sign in / Sign up

Export Citation Format

Share Document